Bayer faces trial test of remaining Roundup claims after US Supreme Court win
Three cancer patients say Monsanto failed to test Roundup adequately as the case tests whether design-defect claims can survive a Supreme Court ruling.
4 Articles
4 Articles
Most recently, Bayer's subsidiary Monsanto was able to gain legal success before the U.S. Supreme Court. Now there is a new lawsuit.
Bayer faces trial test of remaining Roundup claims after US Supreme Court win - Regional Media News
By Dietrich Knauth NEW YORK, Sept 29 (Reuters) - Attorneys for three cancer patients told a Missouri jury on Tuesday that Bayer's Monsanto unit failed to adequately test its Roundup weedkiller before selling it, starting a trial that could help determine the viability of some [...]
Bayer faces trial test of remaining Roundup claims after US Supreme Court win
By Dietrich Knauth NEW YORK, Sept 29 (Reuters) - Attorneys for three cancer patients told a Missouri jury on Tuesday that Bayer's Monsanto unit failed to adequately test its Roundup weedkiller before selling it, starting a trial that could help determi...
Bayer Balances Fresh Pipeline Wins Against a Missouri Courtroom Test
Bayer investors are being pulled in two directions at once. On one side sits a pharma pipeline that just notched two regulatory victories in a matter of days; on the other, a fresh US courtroom battle that could redefine the company’s legal exposure for years to come. The tug-of-war played out in the share price […]
Coverage Details
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
